Mutations in the mismatch repair gene PMS1 and the actin cytoskeleton remodelling gene FNBP1 were subclonally fixed in hEMT cancers, potentially suggesting that acquiring such alterations later during tumour evolution may benefit the establishment of a hybrid phenotype. This evidence concerns the gene PMS1 and cancer.